arrow
J

Josu de la Fuente

Imperial College Healthcare NHS Trust
H指数:37
被引数:6,483

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

输血依赖型地中海贫血造血细胞移植的预处理方案:EBMT实践协调与指南委员会的建议

2026-07-220
PRE
Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party

关于为输血依赖型β-地中海贫血患者选择基因治疗方案的决策算法更新:欧洲血液学协会专业工作组与欧洲血液和骨髓移植协会血红蛋白病工作组联合共识报告

2026-07-160
PRE
Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease

使用硫替派和移植后环磷酰胺的新型减低强度预处理方案在HLA匹配相关供者移植治疗青少年和成人镰状细胞病中取得卓越疗效

2026-04-280
PRE
Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy

镰状细胞病基因治疗:移植与细胞治疗学会和国际细胞与基因治疗学会的实践建议

2026-03-280
OAAI
Implementation of a Dedicated Hematopoietic Stem Cell Transplant Program for Sickle Cell Disease in Lagos, Nigeria: Challenges and Opportunities

在拉各斯尼日利亚实施针对镰状细胞病的专用造血干细胞移植计划的挑战与机遇

2026-01-010
PRE
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI)

英国关于异基因造血干细胞移植(HSCT)后嵌合体检测与监测的建议:英国血液与骨髓移植及细胞治疗学会(BSBMTCT)、英国国家医疗服务体系(NHS England)基因组实验室枢纽(GLH)血液恶性肿瘤工作组、英国癌症遗传学组(UKCGG)以及英国白细胞免疫表型外部质量评估服务(UK NEQAS LI)的最佳实践共识指南。

2025-09-090
OAAI
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene Autotemcel

输血依赖性β-地中海贫血患者在接受Exagamglogene autotemcel治疗后健康相关生活质量改善

2025-08-280
OAAI
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study
2024-05-110
OAAI
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
2024-05-0921
PRE
Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA- Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

在缺乏完全HLA匹配的相关供者的严重再生障碍性贫血患者中,前期替代供者移植与免疫抑制治疗的比较: 代表欧洲血液和骨髓移植小组的严重再生障碍性贫血工作组的回顾性研究的系统评价和荟萃分析

2022-02-0115
OAAI
Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major

基于白消安-氟达拉滨或treosulfan-氟达拉滨的清髓性调理治疗重型地中海贫血患儿

2022-01-0916
PRE
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia
2021-09-0834
OA
Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)
2021-03-0117
OAAI
Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium
2021-02-0117
PREAI
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

镰状细胞病和 β-地中海贫血的CRISPR-Cas9基因编辑

2021-01-211.1K
OAAI
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
2021-01-0827
OAAI
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients
2020-09-1040
OAAI